|
시장보고서
상품코드
2148367
아데노연관바이러스(AAV) 벡터 제조 시장 : 벡터 유형별, 제조 방법별, 용도별, 최종사용자별, 지역별Adeno Associated Virus (AAV) Vector Manufacturing Market, By Vector Type, By Production Method, By Application, By End User, By Geography |
||||||
아데노연관바이러스(AAV) 벡터 제조 시장 규모는 2026년에 31억 8,000만 달러로 추계되고 있으며, 2033년까지 71억 1,000만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 12.2%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 31억 8,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 12.20% | 2033년 시장 규모 예측 : | 71억 1,000만 달러 |
아데노연관바이러스(AAV) 벡터의 제조는 현대 유전자 치료에서 중요한 요소이며, 희귀 질환, 유전성 망막 질환, 혈우병, 중추신경계 질환 등의 치료 용도에서 치료용 유전 물질을 전달하는 비병원성 바이러스 전달 플랫폼을 제공합니다. 이 시장은 상류 공정, 플라스미드 DNA 및 형질 도입 시스템, 하류 공정의 정제, 충전 및 마무리, 품질관리를 포함하는 종단간 제조 생태계를 아우르고 있습니다.
유전자 치료가 임상 개발 단계에서 상업적 응용 단계로 전환됨에 따라 확장 가능하고 수율이 높으며 비용 효율적이고 재현성이 뛰어난 AAV 제조 공정에 대한 수요가 증가하고 있습니다. 바이오의약품 기업, CDMO 및 연구 기관은 수율 및 확장성 문제를 해결하기 위해 최첨단 생산 기술에 투자하고 있으며, 한편 규제 환경의 변화는 AAV 기반 치료법의 개발과 상용화를 촉진하고 있습니다.
시장 역학
전 세계 아데노연관바이러스(AAV) 벡터 제조 시장은 확대되는 유전자 치료 파이프라인, AAV 기반 치료제의 채택 확대, 그리고 바이러스 벡터 제조 인프라에 대한 투자 증가에 힘입어 성장하고 있습니다. 바큐로바이러스 기반 시스템, 개선된 바이오리액터, 최적화된 상류 공정과 같은 생산 기술의 새로운 발전으로 인해 제조업체들은 수율을 향상시키고 운영 규모를 확대할 수 있게 되었습니다.
그러나 아데노연관바이러스(AAV) 벡터 제조 시장의 성장은 높은 제조 비용, 복잡한 제조 공정, 제한된 생산 능력, 그리고 엄격한 품질 요건과 같은 요인들로 인해 제약을 받고 있습니다. 그럼에도 불구하고 차세대 캡시드 공학, 합성 생물학, AI를 활용한 공정 최적화, 그리고 고도로 전문화된 AAV CDMO의 확대에는 큰 기회가 존재합니다. 신흥 시장에서 유전자 치료 개발에 대한 투자 확대는 AAV 제조 생태계의 확장을 더욱 촉진할 것으로 예상됩니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 규명하고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 해설하고 있습니다.
- 또한 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트를 제공합니다.
- 본 조사에서는 다음 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 아데노 관련 바이러스(AAV) 벡터 제조 시장의 주요 기업 개요을 소개하고 있습니다.
- 이 보고서에서 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- 본 ‘글로벌 아데노 관련 바이러스(AAV) 벡터 제조 시장’ 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 아데노 관련 바이러스(AAV) 벡터 제조 시장 분석에 사용된 다양한 전략 매트릭스를 활용하여 원활하게 의사결정을 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 아데노연관바이러스(AAV) 벡터 제조 시장 : 벡터 유형별, 2021-2033년
제5장 세계의 아데노연관바이러스(AAV) 벡터 제조 시장 : 생산 방법별, 2021-2033년
제6장 세계의 아데노연관바이러스(AAV) 벡터 제조 시장 : 용도별, 2021-2033년
제7장 세계의 아데노연관바이러스(AAV) 벡터 제조 시장 : 최종사용자별, 2021-2033년
제8장 세계의 아데노연관바이러스(AAV) 벡터 제조 시장 : 지역별, 2021-2033년
제9장 경쟁 구도
제10장 애널리스트의 제안
제11장 참고 문헌 및 조사 방법
KSA 26.10.19Adeno Associated Virus (AAV) Vector Manufacturing Market is estimated to be valued at USD 3.18 Bn in 2026 and is expected to reach USD 7.11 Bn by 2033, growing at a compound annual growth rate (CAGR) of 12.2% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 3.18 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 12.20% | 2033 Value Projection: | USD 7.11 Bn |
Adeno-Associated Virus (AAV) vector manufacturing is an important element of modern gene therapy, providing a non-pathogenic viral delivery platform for therapeutic genetic material for applications such as rare diseases, inherited retinal disorders, hemophilia and central nervous system conditions. The market encompasses the end-to-end manufacturing ecosystem including upstream processing, plasmid DNA and transfection systems, downstream purification, fill-finish and quality control.
As gene therapy transitions from clinical development to commercial application, the need for scalable, high-yield, cost-effective, and reproducible AAV manufacturing processes is growing. Biopharmaceutical companies, CDMOs, and research institutions are investing in cutting-edge production technologies to address yield and scalability challenges, while changing regulatory landscapes are enabling the development and commercialization of AAV-based therapies.
Market Dynamics
The global adeno associated virus (AAV) vector manufacturing market is driven by the growing gene therapy pipeline, increasing adoption of AAV based therapeutics and rising investments in viral vector manufacturing infrastructure. New developments in production technologies such as baculovirus-based systems, improved bioreactors and optimized upstream processing are enabling manufacturers to improve yields and scale up their operations.
However, the growth of adeno associated virus (AAV) vector manufacturing market is limited by factors such as high production costs, complex manufacturing processes, limited capacity, and stringent quality requirements. Nevertheless, significant opportunities exist in next-generation capsid engineering, synthetic biology, AI-driven process optimization and expansion of specialty AAV CDMOs. Growing investments in gene therapy development across emerging markets are further expected to support expansion of the AAV manufacturing ecosystem.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global adeno associated virus (AAV) vector manufacturing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd, Charles River Laboratories International, Inc., Oxford Biomedica plc, WuXi AppTec Co., Ltd., YposKesi, Sarepta Therapeutics, Inc., Pfizer Inc., Genezen, Creative Biogene, and GenScript Biotech Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global adeno associated virus (AAV) vector manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global adeno associated virus (AAV) vector manufacturing market
Market Segmentation
- Vector Type Insights (Revenue, USD Bn, 2021 - 2033)
- Single-Stranded AAV (ssAAV)
- Self-Complementary AAV (scAAV)
- Production Method Insights (Revenue, USD Bn, 2021 - 2033)
- Transient Transfection
- Baculovirus-Based Production
- Stable Cell Line
- Others
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Gene Therapy
- Cell Therapy
- Vaccine Development
- Research Applications
- Others
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Pharmaceutical and Biotechnology Companies
- Contract Development and Manufacturing Organizations (CDMOs)
- Academic and Research Institutions
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- F. Hoffmann-La Roche Ltd
- Charles River Laboratories International, Inc.
- Oxford Biomedica plc
- WuXi AppTec Co., Ltd.
- YposKesi
- Sarepta Therapeutics, Inc.
- Pfizer Inc.
- Genezen
- Creative Biogene
- GenScript Biotech Corporation
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Adeno Associated Virus (AAV) Vector Manufacturing Market, By Vector Type
- Global Adeno Associated Virus (AAV) Vector Manufacturing Market, By Production Method
- Global Adeno Associated Virus (AAV) Vector Manufacturing Market, By Application
- Global Adeno Associated Virus (AAV) Vector Manufacturing Market, By End User
- Global Adeno Associated Virus (AAV) Vector Manufacturing Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Industry Trends
4. Global Adeno Associated Virus (AAV) Vector Manufacturing Market, By Vector Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Single-Stranded AAV (ssAAV)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Self-Complementary AAV (scAAV)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Adeno Associated Virus (AAV) Vector Manufacturing Market, By Production Method, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Transient Transfection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Baculovirus-Based Production
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Stable Cell Line
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Adeno Associated Virus (AAV) Vector Manufacturing Market, By Application, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Vaccine Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Research Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Adeno Associated Virus (AAV) Vector Manufacturing Market, By End User, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Contract Development and Manufacturing Organizations (CDMOs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Adeno Associated Virus (AAV) Vector Manufacturing Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Production Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Production Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Production Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Production Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Production Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Production Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- F. Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Charles River Laboratories International, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Oxford Biomedica plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- WuXi AppTec Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- YposKesi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sarepta Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Genezen
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Creative Biogene
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GenScript Biotech Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
